v3.25.2
Significant Agreements - Global License Agreement for PRX019 (Details) - Bristol Myers Squibb - USD ($)
$ in Millions
May 24, 2024
Mar. 20, 2018
Collaboration Program, Global, PRX019    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration program, Global Exercise Fee $ 80.0  
Collaboration Agreement, Potential Development and Regulatory Milestone Payments 242.5  
Collaboration Agreement, Potential Commercial Milestone Payments 375.0  
Collaboration Agreement, Allocation of Initial Transaction Price   $ 17.4
Allocated consideration to performance obligations 106.3  
Collaboration Agreement, Total Transaction Price, PRX019 US $ 122.4  
Collaboration program, discount rate 13.00%  
Collaboration Program, US, PRX019    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Collaboration Agreement, Allocation of Initial Transaction Price   $ 24.9
Collaboration Revenue, Development Services for Phase 1 Clinical Trial    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Allocated consideration to performance obligations $ 16.1